MedPath

Comparing the effect of omega-3 with Vitamin E on the treatment of primary dysmenorrhea

Phase 2
Conditions
Dysmenorrhea.
Primary dysmenorrhoea
Registration Number
IRCT201009044686N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

People who have primary dysmenorrheal and use irregular NSAIDS and OCP. Exclusion criteria: Patients with secondary dysmenorrhea (endometriosis, adenomyosis, leiomyoma, uterine anomaly, Endometrial Polyps, ovarian cyst).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain duration. Timepoint: at first and two months after intervention. Method of measurement: based on hours.;Pain intensity. Timepoint: at first and 2 months after intevention. Method of measurement: Based on the VAS pain intensity.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath